Terminated PHASE3 INTERVENTIONAL 2-arm NCT00997490

Study of the Antidepressant Efficacy of a Combination Herbal Drug Preparation (NEURAPAS Balance)

Phase III Placebo-controlled, Randomised, Single-centre, Double-blind Study of the Antidepressant Efficacy of a Combination Herbal Drug Preparation

Sponsor: Pascoe Pharmazeutische Praeparate GmbH

Conditions Depressive Disorder

Interventions Neurapas® balance (Herbal combination out of hypericum, valerian, passionflower) film-coated sugar-pill

Updated 5 times since 2017 Last updated: May 14, 2010 Started: Jan 31, 2001 Primary completion: Jul 31, 2002 Completion: Feb 28, 2003

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

Clearly identifiable benefits 50% of patients included

Other terminated trials from Pascoe Pharmazeutische Praeparate GmbH

More terminations from Pascoe Pharmazeutische Praeparate GmbH

Other Depressive Disorder trials with similar outcome

Browse all Depressive Disorder trials

Listed as NCT00997490, this PHASE3 trial focuses on Depressive Disorder and remains terminated or withdrawn. Sponsored by Pascoe Pharmazeutische Praeparate GmbH, it has been updated 5 times since 2001, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Terminated PHASE3
Jul 2024 — Sep 2024 [monthly]

Terminated PHASE3
Jan 2021 — Jul 2024 [monthly]

Terminated PHASE3
Jun 2018 — Jan 2021 [monthly]

Terminated PHASE3
Jan 2017 — Jun 2018 [monthly]

Terminated PHASE3

First recorded

Jan 2001

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Pascoe Pharmazeutische Praeparate GmbH

Data source: Pascoe Pharmazeutische Praeparate GmbH

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Siegen, Germany